Icon

RASONQUE (NDA220910)- (100MG,150MG)

DARAXONRASIB REVOLUTION MEDICINES
100MG,150MG
No No
2042-Jan-24 2031-Aug-26
None None
None No
RASONQUE is an inhibitor of the RAS GTPase family, indicated for the treatment of adult patients with metastatic pancreatic adenocarcinoma who have received at least one prior systemic therapy or who are not candidates for multiagent systemic therapy.
0 0 0
Total Other Developers None
Drugs with Suitability No
100MG ** ** - - -
150MG ** ** - - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.